Mark Cuban (center), co-founder of Cost Plus Drugs explains his company’s discussions with Humana to develop “direct-to-employer” prescription drug programs that bypass traditional pharmacy benefit companies. Humana CEO Jim Rechtin (right) also spoke with Cuban on a special panel on improving pharmacy experience moderated by Forbes Senior Contributor Bruce Japsen (L) at the Forbes Healthcare […]
Read More